administering < administration < admissions

Facettes :

List of bibliographic references indexed by administration

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000959 (2009)	Addy [États-Unis] ; Assaid [États-Unis] ; Hreniuk [États-Unis] ; Stroh [États-Unis] ; Xu [États-Unis] ; Herring [États-Unis] ; Ellenbogen [États-Unis] ; Jinnah [États-Unis] ; Kirby [États-Unis] ; Leibowitz [États-Unis] ; Stewart [États-Unis] ; Tarsy [États-Unis] ; Tetrud [États-Unis] ; Stoch [États-Unis] ; Gottesdiener [États-Unis] ; Wagner [États-Unis]	Single‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease
000E30 (2008)	Darcy Litteljohn [Canada] ; Emily N. Mangano [Canada] ; Shawn Hayley [Canada]	Cyclooxygenase‐2 deficiency modifies the neurochemical effects, motor impairment and co‐morbid anxiety provoked by paraquat administration in mice
000E57 (2008)	L. Bet [Italie] ; S. R. Bareggi [Italie] ; F. Pacei [Italie] ; G. Bondiolotti [Italie] ; G. Meola [Italie] ; A. H. V. Schapira [Royaume-Uni]	Bimodal administration of entacapone in Parkinson’s disease patients improves motor control
001254 (2006)	David W. Anderson [États-Unis] ; Kristin A. Bradbury [États-Unis] ; Jay S. Schneider [États-Unis]	Neuroprotection in Parkinson models varies with toxin administration protocol
001311 (2006)	J. Antonelle Demarcaida [États-Unis] ; Steven R. Schwid [États-Unis] ; William B. White [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Karl Kieburtz [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis]	Effects of tyramine administration in Parkinson's disease patients treated with selective MAO‐B inhibitor rasagiline
001406 (2005)	Mahmoud M. Iravani [Royaume-Uni] ; Clement C. M. Leung [Royaume-Uni] ; Mona Sadeghian [Royaume-Uni] ; Claire O. Haddon [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation
001778 (2003)	Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure
001A20 (2001)	Jane R. Taylor [États-Unis] ; J. David Jentsch [États-Unis]	Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: differential effects of cocaine, d -amphetamine and 3,4-methylenedioxymethamphetamine (“ecstasy”)
001F13 (1998)	Ronald K. B. Pearce [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]	De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset
002020 (1997)	P. R. Masani [États-Unis]	Homo peccator in public administration
002052 (1997)	Durso [États-Unis] ; James E. Evans [États-Unis] ; Ephraim Josephs [États-Unis] ; George K. Szabo [États-Unis] ; Barbara A. Evans [États-Unis] ; Joseph S. Handler [États-Unis] ; Dana Jennings [États-Unis] ; Thomas R. Browne [États-Unis]	Central levodopa metabolism in Parkinson's disease after administration of stable isotope—labeled levodopa
002184 (1996)	Lj Born [États-Unis] ; Kk Kharbanda [États-Unis] ; Dl Mcvicker [États-Unis] ; Rk Zetterman [États-Unis] ; Tm Donohue Jr [États-Unis]	Effects of ethanol administration on components of the ubiquitin proteolytic pathway in rat liver
002346 (1995)	A. Espino [Espagne] ; J. Llorens [Espagne] ; M. Calopa [Espagne] ; R. Bartrons [Espagne] ; E. Rodriguez-Farre [Espagne] ; S. Ambrosio [Espagne]	Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion
002432 (1994)	T. Ker Nen [Finlande] ; A. Gordin [Finlande] ; M. Karlsson [Finlande] ; K. Korpela [Finlande] ; J. Pentik Inen [Finlande] ; H. Rita [Finlande] ; E. Schultz [Finlande] ; L. Sepp L [Finlande] ; T. Wikberg [Finlande]	Inhibition of soluble catechol- O -methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone
002461 (1994)	G. Ron [Israël] ; Yair Mordish [Israël] ; Avi Eisenthal [Israël] ; Yehuda Skornick [Israël] ; J. Inbar [Israël] ; Samario Chaitchik [Israël]	A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-α2a in patients with advanced malignant melanoma
002D12 (1971)	J. Parizek [Allemagne] ; R. Hassler [Allemagne] ; J. Bak [Allemagne]	Light and electron microscopic autoradiography of substantia nigra of rat after intraventricular administration of tritium labelled norepinephrine, dopamine, serotonin and the precursors

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "administration" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "administration" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    administration
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024